Breaking News
Get 50% Off 0
🚀 June’s AI-picked stocks soar, with Adobe +18.1% in 11 days. Don’t miss July’s upcoming picks. Unlock full list
Close

Abbott Laboratories BDR (ABTT34)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
46.70 0.00    0.00%
18/06 - Delayed Data. Currency in BRL ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 45.78 / 48.99
  • Day's Range: 46.70 - 46.70
Type:  Equity
Market:  Brazil
ISIN:  BRABTTBDR007 
Abbott Laboratories BDR 46.70 0.00 0.00%

ABTT34 Cash Flow Statement

 
Featured here, the Cash Flow Statement for Abbott Laboratories BDR, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 4 periods (either quarterly or annually).
AnnualQuarterly
Advanced Cash Flow Statement
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Period Length: 0 Months 0 Months 0 Months 0 Months
Net Income/Starting Line 1225 1594 1436 1375
Cash From Operating Activities 1025 3038 1877 1203
Depreciation/Depletion 333 332 328 302
Amortization 472 481 496 498
Deferred Taxes - - - -
Non-Cash Items 304 240 117 132
Cash Receipts - - - -
Cash Payments - - - -
Cash Taxes Paid 225 295 343 715
Cash Interest Paid - 662 - -
Changes in Working Capital -1309 391 -500 -1104
Cash From Investing Activities -425 -824 -634 -1213
Capital Expenditures -398 -755 -560 -507
Other Investing Cash Flow Items, Total -27 -69 -74 -706
Cash From Financing Activities -1176 -2052 -2340 -1289
Financing Cash Flow Items - - - -
Total Cash Dividends Paid -957 -888 -888 -890
Issuance (Retirement) of Stock, Net -92 -225 54 -411
Issuance (Retirement) of Debt, Net -127 -939 -1506 12
Foreign Exchange Effects - -24 10 -21
Net Change in Cash -612 187 -1126 -1326
Beginning Cash Balance 6896 6709 7835 9161
Ending Cash Balance 6284 6896 6709 7835
Free Cash Flow 712.25 2122.25 1027.88 681
Free Cash Flow Growth -66.44 106.47 50.94 -37.84
Free Cash Flow Yield 0.317 1.19 0.782 0.367
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABTT34 Comments

Write your thoughts about Abbott Laboratories BDR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email